Edition:
United Kingdom

People: Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

22.43USD
16 Aug 2019
Change (% chg)

$0.64 (+2.94%)
Prev Close
$21.79
Open
$21.89
Day's High
$22.47
Day's Low
$21.81
Volume
208,648
Avg. Vol
182,412
52-wk High
$36.12
52-wk Low
$16.97

Bjerkholt, Eric 

Mr. Eric H. Bjerkholt serves as Chief Financial Officer of the Company. Mr. Bjerkholt has served as our Chief Financial Officer since April 2017. Prior to joining Aimmune, he was CFO at Sunesis Pharmaceuticals, Inc., where, over 13 years with the company, his role expanded to oversee business development and multiple aspects of governance and corporate relations. Prior to Sunesis, Mr. Bjerkholt was CFO at IntraBiotics Pharmaceuticals, Inc., and LifeSpring Nutrition, Inc. He began his healthcare career at J.P. Morgan & Co. as an investment banker in New York and then launched the company’s Western U.S. healthcare practice. Mr. Bjerkholt holds a Cand. Oecon. (master’s) degree in economics from the University of Oslo and an MBA from Harvard Business School. He has served on the boards of directors of several publicly traded companies and is currently a member of the board of directors and chair of the audit committee for Corium International, Inc., a biopharmaceutical company.

Basic Compensation

Total Annual Compensation, USD 3,858,140
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 3,858,140

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --